Icon

ZANVASTRO - (EQ 56MG BASE/2.8ML (EQ 20MG BASE/ML); SOLUTION)

ZILGANERSEN SODIUM IONIS PHARMS INC
EQ 56MG BASE/2.8ML (EQ 20MG BASE/ML); SOLUTION
Less Than $1000 mn
None None
None None
None None
ZANVASTRO is a glial fibrillary acidic protein (GFAP)-directed antisense oligonucleotide indicated for the treatment of Alexander disease in pediatric and adult patients.
Yes
ZANVASTRO Patent 1
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.